The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Neoadjuvant chemoradiation (CRT) for locally advanced rectal cancer (LARC) with or without oxaliplatin (OX): Individual patient data (IPD) meta-analysis of three randomized controlled trials (RCTs) with subgroup analyses of age cohorts.
 
Elisa Fontana
Consulting or Advisory Role - Astellas Pharma (I); Bristol-Myers Squibb (I); Celgene (I); SERVIER (I)
Patents, Royalties, Other Intellectual Property - Patent No: 1716712.3 pending (I)
Travel, Accommodations, Expenses - Bristol-Myers Squibb (I); SERVIER (I)
 
Clizia Zichi
No Relationships to Disclose
 
Elizabeth Catherine Smyth
Consulting or Advisory Role - Astellas Pharma; Bristol-Myers Squibb; Celgene; SERVIER
Patents, Royalties, Other Intellectual Property - Patent No: 1716712.3 pending
Travel, Accommodations, Expenses - Bristol-Myers Squibb; SERVIER
 
Murielle E. Mauer
No Relationships to Disclose
 
Claus Roedel
Research Funding - German Cancer Aid; German Cancer Aid
 
Emmanouil Fokas
No Relationships to Disclose
 
Ralf Dieter Hofheinz
Honoraria - Amgen; Bristol-Myers Squibb; Lilly; Medac; Merck Serono; MSD; Roche; Sanofi
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Merck Serono; MSD; Roche; Sanofi
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Lilly; Merck; MSD; Roche; Sanofi; SERVIER
Research Funding - German Cancer Aid (Inst); Medac (Inst); Sanofi (Inst)
 
Dirk Arnold
Honoraria - Bayer; Bristol-Myers Squibb; Merck Serono; Roche/Genentech; SERVIER; TERUMO
Consulting or Advisory Role - Bayer; Biocompatibles; Bristol-Myers Squibb; Merck Serono; MSD Oncology; Servier; Terumo
Research Funding - Roche/Genentech (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Bayer; Merck Serono; Roche/Genentech
 
Hans-Joachim Schmoll
Honoraria - Amgen; Roche
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Roche
Research Funding - Amgen; Roche
Travel, Accommodations, Expenses - Amgen; Bayer; Roche
 
Eric Van Cutsem
Consulting or Advisory Role - Array BioPharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Celgene; Halozyme; Lilly; Merck KGaA; Merck Sharp & Dohme; Novartis; Roche; SERVIER
Research Funding - amgen (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Ipsen (Inst); Lilly (Inst); Merck (Inst); Merck KGaA (Inst); Novartis (Inst); Roche (Inst); SERVIER (Inst)
 
Karin Haustermans
Honoraria - Varian Medical Systems
Research Funding - Varian Medical Systems
 
Alexander Stein
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Merck KGaA; MSD; Roche
Speakers' Bureau - Amgen; Bayer; Bristol-Myers Squibb; Celgene; Lilly; Merck KGaA; Roche; Sanofi; Servier
Research Funding - Bristol-Myers Squibb (Inst); Merck KGaA (Inst); Roche (Inst); Sanofi (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck KGaA; Roche
 
Jean-Pierre Gerard
No Relationships to Disclose
 
Thierry Conroy
No Relationships to Disclose
 
Claire Jouffroy-Zeller
No Relationships to Disclose
 
Markus H. Moehler
Honoraria - Amgen; AstraZeneca/MedImmune; Bristol-Myers Squibb; Lilly/ImClone; Merck Serono; MSD Oncology; Roche/Genentech; Servier; Taiho Pharmaceutical
Consulting or Advisory Role - Amgen; Bayer; Lilly; Merck Serono; MSD; Nordic Group; Pfizer; Roche; SERVIER; Taiho Pharmaceutical; Yakult Pharmaceutical
Research Funding - Amgen (Inst); AstraZeneca (Inst); Jennerex (Inst); Leap Therapeutics (Inst); Merck Serono (Inst); MSD (Inst)
Travel, Accommodations, Expenses - Amgen; ASCO; Bayer; ESMO; German Cancer Society; Merck Serono; MSD; Roche
 
Florian Lordick
Honoraria - AstraZeneca; BioNTech; Bristol-Myers Squibb; Elsevier; Infomedica; Lilly; Medscape; Merck KGaA; Merck Sharp & Dohme; Roche; SERVIER
Consulting or Advisory Role - Amgen; Astellas Pharma; Beigene; Bristol-Myers Squibb; Lilly; Merck Sharp & Dohme; SERVIER; Zymeworks
Research Funding - Bristol-Myers Squibb (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Lilly
 
Irit Ben-Aharon
No Relationships to Disclose
 
Massimo Di Maio
Honoraria - AstraZeneca; Bristol-Myers Squibb; Eisai; Janssen; Mediolanum Farmaceutici; Merck Sharp & Dohme; Pfizer; Takeda
Consulting or Advisory Role - AstraZeneca; Eisai; Janssen; Mediolanum Farmaceutici; Merck Sharp & Dohme; Pfizer; Takeda
Research Funding - Tesaro (Inst)